This cohort study uses international claims and registry data to describe site of death, health care utilization, and hospital expenditures in the 180-day and 30-day periods before death among elderly patients with cancer in 7 developed countries.
This study assesses associations between measures of aggressive end-of-life care and bereaved family members’ perceptions of the quality of care in Medicare beneficiaries who died of lung or colorectal cancer between 2003 and 2011.
This prospective study uses US Census Bureau surveys matched to the National Death Index to compare the location of death for physicians with that of other health professionals, non–health care professionals with similar education levels, and the general population aged 30 to 98 years who died between 1979 and 2011.
This study uses Medicare death records to compare the intensity of end-of-life care received by physicians, lawyers, and the general US population.
This Viewpoint discusses why physician-assisted death should be considered important enough to be made legally available in all US states.
This Viewpoint reviews the historical roles and ethical obligations of physicians to relieve suffering and in those contexts argues that physician-assisted suicide is never justifiable.
This Viewpoint discusses the debate over physician-assisted dying and the current turning point in public opinion regarding its support.
This Viewpoint traces the history of legalization of physician aid in dying, describes its operational constructs, discusses its ongoing challenges, and considers its future.
This Viewpoint describes efforts in Canada to explore the complexities of physician-assisted death after a 2015 Canadian Supreme Court ruling against its prohibition.
This Viewpoint examines arguments for and against intensive care for patients at the end of life and proposes strategies to ensure the delivery of appropriate and optimal patient-centered care.
This Viewpoint proposes policy options to make hospice care more broadly available to patients and their physicians.
This Viewpoint argues that rapid expansion of programs that protect patients from unwanted resuscitation has outpaced the evidence supporting the programs and may compromise patient-centered decision making more broadly.
This commentary discusses a study published in JAMA Surgery that investigated morbidity and mortality outcomes for battlefield casualties before and after implementation of a “golden hour” rule mandating prehospital helicopter transport of critically injured troops in 60 minutes or less.
A 5-year-old boy presented with erythematous alopecia, crusting, and pustules on the right frontal scalp, without local warmth. He receives prednisone and cyclosporine for nephrotic syndrome; has cervical adenopathy; and owns a cat. Laboratory findings were unremarkable. What would you do next?
A 66-year-old man with mild diabetes, coronary artery disease, and gout presented to the neuromuscular clinic with tingling and weakness in his legs. Results from a neurological examination found uncertainty of the localization of nerve injury, and electrodiagnostic testing revealed normal sural sensory responses. How do you interpret the test results?
This Medical News & Perspectives article highlights a presentation at the American Public Health Association’s annual meeting that addressed economic conditions, health spending, and mortality.